Validation of a new score for outcome prediction in patients with heart failure with reduced ejection fraction

被引:4
|
作者
Loiacono, Ferdinando [1 ]
Fragasso, Gabriele [2 ]
Calori, Giliola [2 ]
Alberti, Luca [2 ]
Marinosci, Giovanni [2 ]
Salerno, Anna [2 ]
Margonato, Alberto [2 ]
机构
[1] Univ Siena, Dept Cardiovasc Dis, Viale Mario Bracci 16, I-53100 Siena, Italy
[2] Osped San Raffaele, Dept Clin Cardiol, I-20132 Milan, Italy
来源
MINERVA CARDIOANGIOLOGICA | 2019年 / 67卷 / 03期
关键词
Heart failure; Morbidity; Mortality; Prognosis; RISK SCORE; MORTALITY; MANAGEMENT; MORBIDITY; SURVIVAL; DISEASE; MODELS;
D O I
10.23736/S0026-4725.19.04823-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Most models for outcome prediction in heart failure are under-utilized because complex or including non-routine clinical use variables. We aimed to develop a prognostic score for patients with stable heart failure, including only easily obtainable parameters. METHODS: In 376 outpatients with heart failure (ejection fraction <= 40%), twelve variables were individually correlated with 5-year mortality. Those resulted significant predictors of cardiac and overall mortality were used to obtain a risk score. It was validated on a different sample of 325 patients previously enrolled in other clinical studies, according to tertiles of score. RESULTS: Previous acute decompensated heart failure, atrial fibrillation, ejection fraction <30%, not-taking beta-blockers, chronic renal failure were the variables included in the final model. There was a significant difference in 5-year cardiac (P=0.004) and all-cause (1 3 =0.003) mortality risk. Compared to the first tertile of the score, the second tertile and the third Willie had an increasing risk for cardiac cause admission (respectively, HR: 2.7; 95% CI: 1.5-4.9 and HR: 3.2; 95% CI: 1.7-6.1) and for heart failure worsening hospitalization (HR:4.3; 95% CI: 1.3-14.5 and HR: 3.8; 95% CI: 1.03-14.1) as well as the third tertile (respectively. HR:3.2; 95% CI: 1.7-6.1 and HR:3.8; 95% CI: 1.03-14.1.). CONCLUSIONS: Our prognostic model, named OSR HF Risk Score, is a simple, quick, inexpensive tool for predicting patient outcome in 5 years. It might be used as an adjunctive tool in outpatients evaluation alongside more complex scores.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 50 条
  • [41] Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction The Importance of Atrial Strain by Speckle Tracking Echocardiography
    Carluccio, Erberto
    Biagioli, Paolo
    Mengoni, Anna
    Cerasa, Maria Francesca
    Lauciello, Rosanna
    Zuchi, Cinzia
    Bardelli, Giuliana
    Alunni, Gianfranco
    Coiro, Stefano
    Gronda, Edoardo G.
    Ambrosio, Giuseppe
    CIRCULATION-CARDIOVASCULAR IMAGING, 2018, 11 (11) : e007696
  • [42] Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
    Talha, Khawaja M.
    Butler, Javed
    CLINICAL CARDIOLOGY, 2022, 45 : S31 - S39
  • [43] Comparison of the prognosis and outcome of heart failure with reduced ejection fraction patients treated with sacubitril/valsartan according to age
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Kummer, Marvin
    Pilsinger, Christina
    Sattler, Katherine
    Kuschyk, Juergen
    Aweimer, Assem
    Muegge, Andreas
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2021, 17 (06) : 1131 - 1142
  • [44] Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute Decompensated Heart Failure with Reduced and Mildly Reduced Ejection Fraction
    Asano, Takaaki
    Maeno, Yoshio
    Nakano, Masataka
    Taguri, Masataka
    Miyasaka, Masaki
    Nakai, Daisuke
    Miyazaki, Itaru
    Nasu, Takahito
    Tanimoto, Shuzou
    Masuda, Naoki
    Morino, Yoshihiro
    Isshiki, Takaaki
    Ogata, Nobuhiko
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [45] Heart Failure with Reduced Ejection Fraction in Women Epidemiology, Outcomes, and Treatment
    Mentzer, Gina
    Hsich, Eileen M.
    HEART FAILURE CLINICS, 2019, 15 (01) : 19 - +
  • [46] Conception and bicentric validation of the proSCANNED score, a simplified bedside prognostic score for Heart Failure patients
    Duflos, Claire
    Solecki, Kamila
    Galinier, Michel
    Itier, Romain
    Roncalli, Jerome
    Goger, Anne-Laure
    Mandoraah, Bara
    Kalmanovich, Eran
    Huet, Fabien
    Agullo, Audrey
    Delseny, Delphine
    Macia, Jean-Christophe
    Leclercq, Florence
    Mercier, Gregoire
    Roubille, Francois
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction
    Nichols, Gregory A.
    Qiao, Qing
    Deruaz-Luyet, Anouk
    Kraus, Bettina J.
    IJC HEART & VASCULATURE, 2023, 47
  • [48] Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction The EMPEROR-Reduced Trial
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Brueckmann, Martina
    Jamal, Waheed
    Zeller, Cordula
    Schnaidt, Sven
    Zannad, Faiez
    CIRCULATION, 2021, 143 (04) : 326 - 336
  • [49] Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar
    Rahhal, Alaa Abdullah
    Awaisu, Ahmed
    Tawengi, Kawthar M.
    AbuYousef, Safae
    Mekideche, Lylia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (05) : 1070 - 1083
  • [50] Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction
    Watanabe, Yusuke
    Horiuchi, Yu
    Nakase, Masaaki
    Setoguchi, Naoto
    Ishizawa, Taiki
    Sekiguchi, Masahiro
    Nonaka, Hideaki
    Nakajima, Momoka
    Asami, Masahiko
    Yahagi, Kazuyuki
    Komiyama, Kota
    Yuzawa, Hitomi
    Tanaka, Jun
    Aoki, Jiro
    Tanabe, Kengo
    HEART AND VESSELS, 2022, 37 (11) : 1841 - 1849